Himadri Speciality Chemical Ltd
Himadri Speciality Chemical Ltd
CommoditiesKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTechnical Indicators
Key Insights
Strengths
1- Company has delivered good profit growth of 73.7% CAGR over last 5 years
Weaknesses
1- Stock is trading at 7.11 times its book value
Growth Rate
AI Analysis — Bull vs Bear
Himadri Speciality Chemical has delivered exceptional profit growth of 74% CAGR over 5 years and strong stock returns of 61% CAGR over the same period, but trades at a stretched PE of 42.7x with near-flat TTM sales growth of just 1%, suggesting most of the good news is priced in. The sole analyst covering the stock rates it a Hold, and the valuation leaves little margin of safety at the current market cap of Rs 32,727 Cr.
- Outstanding 5-year compounded profit growth of 74% CAGR demonstrates strong earnings scalability and operating leverage
- ROE improved to 18% last year from 14% five-year average, indicating improving capital efficiency and return generation
- Stock has delivered 70% CAGR returns over 3 years, reflecting sustained market confidence and momentum
- 10-year compounded profit growth of 44% CAGR shows this is not a one-cycle story but a structural compounder
- 5-year compounded sales growth of 23% CAGR indicates the company has scaled revenues meaningfully over a longer horizon
- 3-year ROE of 17% is well above cost of equity for most chemical companies, creating consistent shareholder value
- Market cap of Rs 32,727 Cr positions it as a mid-to-large cap specialty chemical player with institutional ownership potential
- TTM sales growth has collapsed to just 1%, a sharp deceleration from the 23% 5-year CAGR, signaling potential demand slowdown
- PE ratio of 42.7x is expensive for a chemicals company with near-zero revenue growth, leaving no room for execution misses
- Price-to-book of 6.85x is elevated and implies the market is pricing in significant future growth that may not materialize
- Dividend yield of only 0.13% offers negligible income protection and suggests the stock is priced purely for capital gains
- Only 1 analyst covers the stock with a Hold rating and 0 Buy recommendations, indicating limited institutional conviction
- 1-year stock CAGR of 45% has run well ahead of TTM profit growth of 35%, suggesting price has outpaced fundamentals
- 3-year sales CAGR of only 4% versus 47% profit CAGR suggests margin expansion may be peaking and is unsustainable without topline recovery
- Absence of reported debt-to-equity, EPS, and ROCE data limits visibility into balance sheet health and capital allocation efficiency
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Stake in IBC raised to 20.47% Jun 18
Himadri invested USD 0.66 Million in International Battery Company, raising its stake to 20.47% with total investment cost of USD 6.09 Million, signaling continued commitment to the EV battery materials space.
- New Mumbai office opened Jun 20
Himadri Speciality Chemical opened a new office in Mumbai on June 20, 2026, to strengthen its presence in the Western Region.
- ₹17.70 Cr block trade on NSE Jun 9
A block trade of approximately 270,075 shares at ₹655.50 per share worth ₹17.70 crores was recorded on the NSE, indicating sustained institutional interest in the stock.
TL;DR: Himadri Speciality Chemical shows steady strategic progress with incremental investments in battery materials via IBC and geographic expansion through its new Mumbai office. Institutional interest remains evident from the ₹17.70 Cr block trade. No notable headwinds emerged in recent weeks. The trend appears stable with a mild positive tilt as the company deepens its positioning in the EV value chain.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 | 1,071 | 1,184 | 1,288 |
| Expenses | 903 | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 | 838 | 941 | 1,046 |
| Operating Profit | 126 | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 | 233 | 243 | 242 |
| OPM % | 12% | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% | 22% | 20% | 19% |
| Other Income | 11 | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 | 36 | 47 | 62 |
| Interest | 13 | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 | 15 | 16 | 17 |
| Depreciation | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 | 17 | 18 | 19 |
| PBT | 111 | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 | 237 | 255 | 268 |
| Tax % | 31% | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% | 26% | 25% | 23% |
| Net Profit | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 | 176 | 192 | 208 |
| EPS in Rs | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 | 3.57 | 3.81 | 3.98 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,661 |
| Expenses | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,699 |
| Operating Profit | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 962 |
| OPM % | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% |
| Other Income | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 171 |
| Interest | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 64 |
| Depreciation | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 68 |
| PBT | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 1,001 |
| Tax % | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | 25% |
| Net Profit | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 755 |
| EPS in Rs | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 14.89 |
| Div. Payout % | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% | 5% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 50 |
| Reserves | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,656 |
| Borrowings | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 770 |
| Other Liabilities | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 830 |
| Total Liabilities | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 |
| Fixed Assets | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,942 |
| CWIP | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 372 |
| Investments | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 1,060 |
| Other Assets | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,933 |
| Total Assets | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 212 | 296 | 205 | 258 | 476 | 283 | -40 | 331 | 54 | 405 | 447 | 382 |
| Investing | 128 | -6 | 10 | -50 | -224 | -214 | -114 | -28 | -397 | -405 | -235 | -963 |
| Financing | -348 | -278 | -233 | -200 | -257 | -41 | 165 | -182 | 377 | 7 | -271 | 590 |
| Net Cash Flow | -7 | 12 | -18 | 8 | -6 | 28 | 11 | 121 | 34 | 7 | -60 | 10 |
| Free Cash Flow | 184 | 281 | 201 | 195 | 272 | 36 | -76 | 308 | -22 | 352 | 276 | -63 |
| CFO/OP | 169 | 203 | 98 | 75 | 102 | 113 | -20 | 223 | 25 | 77 | 69 | 64 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 | 55 |
| Inventory Days | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 | 96 |
| Days Payable | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 | 47 |
| Cash Conversion Cycle | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 | 103 |
| Working Capital Days | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 | 57 |
| ROCE % | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% | 22% |
Documents
Frequently Asked Questions about Himadri Speciality Chemical Ltd
What does Himadri Speciality Chemical Ltd do?
Where is Himadri Speciality Chemical Ltd (HSCL) listed?
Which sector does Himadri Speciality Chemical Ltd belong to?
What is the market capitalisation of Himadri Speciality Chemical Ltd?
What is the PE ratio of Himadri Speciality Chemical Ltd?
What is the 52-week high and low of Himadri Speciality Chemical Ltd?
Does Himadri Speciality Chemical Ltd pay dividends?
What is the Return on Equity (ROE) of Himadri Speciality Chemical Ltd?
How can I research Himadri Speciality Chemical Ltd on Tapetide?
Company Information
Himadri Speciality Chemical is primarily engaged in the manufacturing of carbon materials and chemicals.[1] It is the No.1 coal pitch manufacturer in India and is the only company to manufacture advanced carbon material in India. It is also the largest player of Naphthalene and SNF in India.[2]